Some authors studied TP53 mutation and concluded that it is more frequent in MIBC compared to NMIBC (35 vs. 70%), and found a correlation with stage, grade, and recurrence of bladder cancer [42,43,44]. This evidence concerns the gene TP53 and urinary bladder carcinoma.